Growing prevalence of cancer and other rare life threatening disorders such as HIV, increased research and development, cost effectiveness of genomic sequences are the growth propellers for bioinformatics in vitro diagnosis (IVD) market. The collaboration of bioinformatics IVD companies with IT companies to design specific software for diagnosis of inherited or non curable disease is another vital driver for this market. The bioinformatics based diagnosis made a significant contribution to cancer diagnosis and its therapy management. It also allows detection of tough culture pathogens (viruses or bacteria) to understand the infection epidemiology. Bioinformatics in IVD testing market diagnoses inherited diseases, common disorders and also indicates the initiation of malignancy.
The global bioinformatics in vitro diagnosis (IVD) market is segmented on the basis of application and region. The market is segmented into bioinformatics based diagnosis for cardiovascular diseases, chronic diseases, diabetes, and cancer. Other diseases that can be diagnosed using bioinformatics IVD testing system are Alzheimer’s disease, Parkinson’s disease, gastrointestinal disorder, genome sequencing, mass spectroscopy diagnosis, arthritis, tissue based diagnosis, blood based diagnosis and psychiatric disorders.
Various IT companies such as IBM collaborates laboratory diagnosis vendors and the manufacturers for designing specific software for specific disease condition that will compliment human based diagnosis during the forecast period. Different IT related organizations enter into alliances with research institutes which provides platform for biomedicines for novel and cost effective drugs for incurable disorders. One such technological innovation is IBM’s supercomputer named “Watson” which uses stored database and recommends suitable treatment on a patient to patient basis.
On the basis of region, market for temperature monitoring devices is segmented into North America, Europe, Asia-Pacific and RoW. North America holds the largest market share in this market presently due to the increase in health awareness and rise in patient expenditure. Asia-Pacific is expected to capture the market in the forecast period due to the rising prevalence of cancer and other rare diseases.
The key players of this market are Affymetrix, AssureRx Health Inc, Aperico Technologies Inc, Biodesix Inc, Bioreference Laboratories Inc, CardioDx Inc, Datech Oncology, Life Technologies, Pathogenica, Medtronic Inc, Signal genetics and One Lambda Inc.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.